Upcoming Events
Log In
Pricing
Free Trial

Discordant Result

HIDE
PrevNext

0:00

So challenge number 13.

0:01

This is a patient who, on her diagnostic study,

0:05

here's the post GAD image and here is the subtraction image.

0:09

So she had clumped linear enhancement.

0:12

So this is pretty concerning for non mass enhancement.

0:15

You know, you're, you're pretty worried that's going to be,

0:17

um, DCIS.

0:19

Here's her post biopsy MR Study.

0:23

You can see she's got air in the cavity here, a little bit

0:26

of hemorrhage or fluid up here.

0:28

And it looks like the sampling was

0:30

really, you know, pretty good.

0:31

It looks like it was in the right place,

0:33

and yet this came back as being fibrocystic change.

0:36

So the question is, is it a non concordant biopsy or not?

0:41

Um, when they've done studies, there's actually some kind

0:44

of frightening figures out there for guided biopsies

0:46

and they have shown that, uh, up to 15%, 14% of lesions

0:51

that are targeted are inadequately sampled.

0:53

If you do a follow-up gadolinium enhanced MR study,

0:56

and this has come from a couple of studies,

0:58

so in other words, you think you've got it,

1:00

you're completely happy with it, you think it's concordant,

1:03

you do a follow-up study and no, you haven't,

1:04

whether it's benign or malignant.

1:06

And overall the amount of false negative

1:09

MR guided biopsies is 2.5%, which is significantly higher

1:14

than it is for stereo tactical and ultrasound guided biopsy.

1:19

So if you get a result

1:20

that you are concerned may be discordant

1:22

and you do the same rad path correlation you do with,

1:25

you know, anything else that we biopsy, any other way

1:27

that we biopsy in breast imaging, the first thing you want

1:30

to do is check the adequacy of your biopsy.

1:32

So look back, look at where the cavity was compared to your,

1:37

um, prebi gadolinium enhanced study.

1:40

Look at where the clip is on the post mammogram

1:43

and then depending on how concerned about it,

1:46

you could do a couple of different things.

1:47

You could do a short interval follow up

1:49

and I wouldn't really wait six to months

1:52

unless you have very low concern about this lesion.

1:56

I think six to eight weeks is the

1:57

more appropriate follow up.

1:59

You can then take them back

2:00

and re-biopsy them if, um, you see

2:03

that the lesion is still there

2:05

and you could set them up for a, um,

2:07

diagnostic slash biopsy slots, you already

2:10

to go in one go if you wish.

2:12

At that point, um, you could take them back

2:15

and do an MR guided needle lo at the lesion,

2:18

or you could do a regular mammographic needle lo using

2:21

the clip placed in biopsy.

2:23

If you consider that that is in the right position

2:25

and probably getting the surgeon to be reasonably generous

2:28

with their biopsies.

Report

Text

Faculty

Petra J Lewis, MBBS

Professor of Radiology and OBGYN

Dartmouth-Hitchcock Medical Center & Geisel School of Medicine at Dartmouth

Tags

Women's Health

Non-infectious Inflammatory

Neoplastic

MRI

Idiopathic

Diagnosis & Staging

Breast